SLN
Silence Therapeutics
SLN
SLN
56 hedge funds and large institutions have $108M invested in Silence Therapeutics in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
32% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 19
Holders
56
Holding in Top 10
2
Calls
$132K
Puts
$7K
Top Buyers
| 1 | +$1.4M | |
| 2 | +$705K | |
| 3 | +$219K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$161K |
| 5 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$157K |
Top Sellers
| 1 | -$4.57M | |
| 2 | -$4.05M | |
| 3 | -$1.15M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.13M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$1.04M |
